Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens

Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world, causing ~1.5 million deaths every year. The World Health Organization initiated an End TB Strategy that aims to reduce TB-related deaths in 2035 by 95%. Recent research goals have focused on discovering more eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Budak, Maral, Cicchese, Joseph M., Maiello, Pauline, Borish, H. Jacob, White, Alexander G., Chishti, Harris B., Tomko, Jaime, Frye, L. James, Fillmore, Daniel, Kracinovsky, Kara, Sakal, Jennifer, Scanga, Charles A., Lin, Philana Ling, Dartois, Véronique, Linderman, Jennifer J., Flynn, JoAnne L., Kirschner, Denise E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306236/
https://www.ncbi.nlm.nih.gov/pubmed/37319311
http://dx.doi.org/10.1371/journal.pcbi.1010823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306236/
https://www.ncbi.nlm.nih.gov/pubmed/37319311
http://dx.doi.org/10.1371/journal.pcbi.1010823

Ejemplares similares